Texas Trailblazer: Ann Stevens

Add this event to your calendar:
25/01/2018 17:30 25/01/2018 20:30 America/Chicago Texas Trailblazer: Ann Stevens JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021 JLABS @ TMC false DD/MM/YYYY

Texas Trailblazer: Ann Stevens

JLABS @ TMC , John P. McGovern Campus , Houston , TX 77021

January 25, 2018 from 17:30 PM to 20:30 PM (CST)

$10 - $35

Expert InsightIn the Lone Star State, Texans have a pride that’s unmatched, and in the new Texas Trailblazers series at JLABS @ TMC, we’re tapping into these hometown heroes that have been brave enough to forge into the unknown and make a real difference in their industries. The Texas Trailblazers are an elite group of Texans that have achieved insurmountable successes in their endeavors, and JLABS @ TMC is providing a platform for them to discuss their failures, successes, and advice for budding entrepreneurs.

4:30 PM | Registration Opens, Networking 
5:00 PM | Presentation  
6:00 PM | Q&A
7:00 PM | Program Close

Ann Stevens | President of BioMed, San Antonio, former Director of Corporate Communications and Investor Relations for ILEX Oncology, Inc read bio»

 $15 | General Public

John P. McGovern Campus
2450 Holcombe Blvd, Suite J
Houston, TX 77021

Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.

Speaker Biography:

Ann Stevens | President of BioMed, San Antonio, Former Director of Corporate Communications and Investor Relations for ILEX Oncology, Inc

As Founding President of the non-profit corporation, BioMed SA, Ann Stevens brings a unique combination of experience in the biomedical field, investment community and media industry – along with a collaborative leadership style and a passion for community service – to her role of promoting and growing San Antonio ’s leading industry, healthcare and the biosciences. In this role, she fosters the growth of local startup companies as well as homegrown industry leaders; helps recruit biomedical companies to San Antonio, and travels throughout the nation and world to raise the visibility of San Antonio as a City of Science and Health.

Before accepting her leadership role with BioMed SA in 2005, Stevens spent eight years as Director of Corporate Communications and Investor Relations for ILEX Oncology, Inc., San Antonio’s first publicly traded biopharmaceutical company. She was a key member of the leadership team that raised the market capitalization of this homegrown, startup company from under $100 million to its final acquisition price by Genzyme Corporation of $1 billion in December 2004. While at ILEX, Stevens participated in getting two new anti-cancer drugs approved by the FDA, representing new hope for patients with leukemia, and experienced first-hand the difference this industry can make in people’s lives.

She also developed a strong working knowledge of the biotechnology and pharmaceutical industry, partnering with other drug companies and interfacing regularly with peer companies, investors and physicians at national medical meetings and investment banking conferences. Community relations has been an integral component of Stevens’ career experience. At ILEX, she served as the company’s primary representative within the San Antonio Chamber of Commerce, the SATAI Network, the San Antonio-Austin Life Sciences Association, and other business and industry groups. She was a member of Leadership San Antonio Class XXIX and for two years chaired publication of The Greater Chamber’s Healthcare & Bioscience Economic Impact Study. Prior to joining ILEX, Stevens spent 17 years on the corporate staff of global media firm, Harte-Hanks, Inc., where she served as Director of Corporate Communications. She began her career as a reporter for two Harte-Hanks daily newspapers in West Texas. She holds a B.A. degree in journalism from Texas State University (formerly Southwest Texas State University), graduating with highest honors, and was named a Distinguished Alumna in 2013.

A native Texan and 35-year resident of San Antonio, Stevens is a co-founder and past president of the San Antonio chapter of the National Investor Relations Institute. She was also a two-term president and former Communicator of the Year of the San Antonio chapter of the International Association of Business Communicators. She was honored by the San Antonio Business Journal in 2014 with Women’s Leadership Awards for Non-Profit Leadership and Community Leader of the Year.




Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

Event contact

Related content